Back to Search
Start Over
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper.
- Source :
-
Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 552-564. Date of Electronic Publication: 2023 Nov 27. - Publication Year :
- 2024
-
Abstract
- Proton pump inhibitors (PPIs) are invaluable therapeutic options in a variety of dyspeptic diseases. In addition to their well-known risk profile, PPI consumption is related to food and environmental allergies, dysbiosis, osteoporosis, as well as immediate and delayed hypersensitivity reactions (HSRs). The latter, although a rare event, around 1%-3%, due to the extraordinarily high rate of prescription and consumption of PPIs are related to a substantial risk. In this Position Paper, we provide clinicians with practical evidence-based recommendations for the diagnosis and management of HSRs to PPIs. Furthermore, the unmet needs proposed in the document aim to stimulate more in-depth investigations in the topic.<br /> (© 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.)
Details
- Language :
- English
- ISSN :
- 1398-9995
- Volume :
- 79
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Allergy
- Publication Type :
- Academic Journal
- Accession number :
- 38013608
- Full Text :
- https://doi.org/10.1111/all.15961